š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
We have been using DEX for refractory DME for a long time (since 2016). Thu...
Status
Completed
Location
Kasr alainy faculty of medicine
Start Date
2023-02-15
Trial ID
NCT05847088
Treatments Being Tested
This is an investigator-initiated Phase I study of a single dose of an intr...
Status
Completed
Location
Anne Marie Lane
Start Date
2018-12-11
Trial ID
NCT04082962
Treatments Being Tested
This study is an interventional, prospective randomized study comparing the...
Status
Completed
Location
Retina Consultants of Houston
Start Date
2020-04-10
Trial ID
NCT04411693
Treatments Being Tested
The Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Appli...
Status
Completed
Location
Global Research Management /ID# 238944
Start Date
2021-10-12
Trial ID
NCT04976777
Treatments Being Tested
The Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (ME...
Status
Completed
Location
Jules Stein Eye Institute, UCLA
Start Date
2017-03-09
Trial ID
NCT02623426
A retrospective, non-interventional, observational, multi-center, drug util...
Status
Completed
Location
Clinical Trials Registry Team
Start Date
2019-01-15
Trial ID
NCT03889444
Treatments Being Tested
This is a 12-month, prospective, randomized controlled, multi-center, open-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-15
Trial ID
NCT07438119
An epiretinal membrane is scar tissue on the retina that can cause blurring...
Status
Completed
Location
Retina Specialists PC
Start Date
2010-06
Trial ID
NCT01273727
Treatments Being Tested
This study will use retrospective data to evaluate the efficacy, safety, an...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01445626
Treatments Being Tested
This is a study designed to determine if the addition of OzurdexĀ® to bevaci...
Status
Completed
Location
Texas Retina Associates
Start Date
2011-05
Trial ID
NCT01295112
Treatments Being Tested